Kevin E. Lofton - 12 May 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Reporting relationship: Director
Issuer ticker: GILD
Reported as of: 12 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2021, 16:04:37 UTC
Next SEC filing: 01 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Amy Kim by Power of Attorney for Kevin E. Lofton

Key filing fact

Kevin E. Lofton filed Form 4 for GILEAD SCIENCES INC (GILD) on 14 May 2021.

Key facts

This page summarizes Kevin E. Lofton's Form 4 filing for GILEAD SCIENCES INC (GILD).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 May 2021, 16:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +2,223
Change %: +23%
Price
Shares after: 12,053
Date: 12 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,223
Exercise price
Footnotes: F1, F2

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +14,665
Change %
Price: $0.000000
Shares after: 14,665
Date: 12 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,665
Exercise price: $67.45
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Footnote F2

100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.

Footnote F3

25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.